$2.185
-0.109 (-5.00%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BridgeBio Oncology Therapeutics Inc (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.56, suggesting BBOT is Strong sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 20-Day simple moving average is 2.73, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $—, making it Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 60-Day simple moving average is 5.24, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $—, making it Sell.
Technical Analysis for BBOT
AI Technical BBOTAs of 2026-11-02, the technical board for BridgeBio Oncology Therapeutics Inc (BBOT) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $2.17 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 18.99, MACD stands at -0.564 (Sell), Stochastic %K stands at 8.707 (Buy), Stochastic %D stands at 6.532 and CCI stands at -172.523 (Buy).
BBOT trades below the 60-day SMA (5.24) and below the 200-day SMA (7.95). Immediate resistance sits at Classic R1 2.96, then R2 3.39. Support sits at Classic S1 2.08, then S2 1.64.
BridgeBio Oncology Therapeutics Inc (BBOT) Support & Resistance Level
BridgeBio Oncology Therapeutics Inc (BBOT) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 18.990 |
| STOCHk_14_3_3 | 8.707 |
| STOCHd_14_3_3 | 6.532 |
| CCI_20 | -172.523 |
| AO_5_34 | -0.872 |
| MOM_10 | -0.665 |
| MACD_12_26_9 | -0.564 |
BridgeBio Oncology Therapeutics Inc (BBOT) Relative Strength Index (RSI_14) is 18.990, creating a Buy signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Stochastic %K is 8.707, creating a Buy signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Stochastic %D is 6.532, creating a Buy signal.
BridgeBio Oncology Therapeutics Inc (BBOT) CCI_20 is -172.523, creating a Buy signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Awesome Oscillator (AO) is -0.872, creating a Sell signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Momentum (MOM) is -0.665, creating a Sell signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Moving Average Convergence Divergence (MACD) is -0.564, creating a Sell signal.
BridgeBio Oncology Therapeutics Inc (BBOT) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.347 | Sell |
| MA_10 | 2.522 | Sell |
| MA_20 | 2.726 | Sell |
| MA_60 | 5.235 | Sell |
| MA_200 | 7.951 | Sell |
| MA_250 | 8.820 | Sell |
BridgeBio Oncology Therapeutics Inc (BBOT) 5-Day simple moving average is 2.347, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 10-Day simple moving average is 2.522, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 20-Day simple moving average is 2.726, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 60-Day simple moving average is 5.235, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 200-Day simple moving average is 7.951, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
BridgeBio Oncology Therapeutics Inc (BBOT) 250-Day simple moving average is 8.820, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.